Leonardo Clavijo

3.4k total citations
77 papers, 1.7k citations indexed

About

Leonardo Clavijo is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonardo Clavijo has authored 77 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 44 papers in Cardiology and Cardiovascular Medicine and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonardo Clavijo's work include Coronary Interventions and Diagnostics (28 papers), Peripheral Artery Disease Management (21 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Leonardo Clavijo is often cited by papers focused on Coronary Interventions and Diagnostics (28 papers), Peripheral Artery Disease Management (21 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Leonardo Clavijo collaborates with scholars based in United States, Australia and United Kingdom. Leonardo Clavijo's co-authors include Ron Waksman, Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler, William W. Chu, Pramod K. Kuchulakanti, William O. Suddath, Rebecca Torguson, Eugenio Stabile and Natalie Gevorkian and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Applied Physiology.

In The Last Decade

Leonardo Clavijo

69 papers receiving 1.7k citations

Peers

Countries citing papers authored by Leonardo Clavijo

Since Specialization

Citations

This map shows the geographic impact of Leonardo Clavijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonardo Clavijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonardo Clavijo more than expected).

Fields of papers citing papers by Leonardo Clavijo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonardo Clavijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonardo Clavijo. The network helps show where Leonardo Clavijo may publish in the future.

Co-authorship network of co-authors of Leonardo Clavijo

This figure shows the co-authorship network connecting the top 25 collaborators of Leonardo Clavijo. A scholar is included among the top collaborators of Leonardo Clavijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonardo Clavijo. Leonardo Clavijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial 2024 ·Journal of Vascular Surgery ·Matthew T. Menard, Alik Farber, Gheorghe Doros, (unknown), Emiliano Chisci, Leonardo Clavijo, Ahmed Kayssi, Peter A. Schneider, Beau M. Hawkins, Michael D. Dake, Taye H. Hamza, Michael B. Strong, Kenneth Rosenfield, Michael S. Conte	2
2	Baseline modern medical management in the BEST-CLI trial 2023 ·Journal of Vascular Surgery ·Matthew T. Menard, Michael R. Jaff, Alik Farber, Kenneth Rosenfield, Michael S. Conte, Christopher J. White, Joshua A. Beckman, Niteesh K. Choudhry, Leonardo Clavijo, Thomas S. Huber, Katherine R. Tuttle, Taye H. Hamza, Andres Schanzer, Igor Laskowski, Mark J. Cziraky, Alain Drooz, Max van Over, Michael B. Strong, Ido Weinberg	15
3	Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trial 2022 ·Journal of Vascular Surgery ·Jeffrey J. Siracuse, Vincent L. Rowe, Matthew T. Menard, Kenneth Rosenfield, Michael S. Conte, Richard J. Powell, Leonardo Clavijo, Kristina A. Giles, Taye H. Hamza, Max van Over, (unknown), Christopher J. White, Michael B. Strong, Alik Farber	11
4	Factors Associated With the Use of Bare Metal Stents in Patients With ST Elevation Myocardial Infarction 2020 ·Cardiovascular revascularization medicine ·(unknown), (unknown), Leonardo Clavijo, (unknown), Anilkumar Mehra, (unknown), Ray Matthews, David M. Shavelle	0
5	How to Create a Hot Foot Line to Prevent Diabetes-Related Amputations: Instant Triage for Emergency Department and Inpatient Consultations 2019 ·Journal of the American Podiatric Medical Association ·John D. Miller, (unknown), Nicholas A. Giovinco, (unknown), Vincent L. Rowe, Leonardo Clavijo, Fred A. Weaver, David G. Armstrong	3
6	Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials 2018 ·Cardiovascular revascularization medicine ·Ramez Nairooz, Marwan Saad, Ashwat Dhillon, (unknown), (unknown), Anilkumar Mehra, Ray Matthews, David M. Shavelle, Leonardo Clavijo	6
7	Increased risk of mortality after lower extremity bypass in individuals with acute kidney injury in the Vascular Quality Initiative 2016 ·Journal of Vascular Surgery ·(unknown), Juan Pablo Lewinger, Vincent L. Rowe, Karen Woo, Fred A. Weaver, David M. Shavelle, Leonardo Clavijo, Parveen K. Garg	11
8	CRT-128 Safety of Rotational Atherectomy in High Risk PCI with Hemodynamic Support 2015 ·JACC: Cardiovascular Interventions ·(unknown), (unknown), Michael A. Gaglia, Anilkumar Mehra, Ray Matthews, David M. Shavelle, Leonardo Clavijo	0
9	CRT-25 Young Patients With Acute Myocardial Infarction: How Are They Different? 2013 ·JACC: Cardiovascular Interventions ·(unknown), (unknown), (unknown), (unknown), David M. Shavelle, Anilkumar Mehra, Michael A. Gaglia, Ray Matthews, Leonardo Clavijo	1
10	“RESISTANCE” OR HIGH ON-TREATMENT PLATELET REACTIVITY TO ASPIRIN AND CLOPIDOGREL IN PATIENTS WITH CRITICAL LIMB ISCHEMIA 2012 ·Journal of the American College of Cardiology ·Sarah Elsayed, David M. Shavelle, Ray Matthews, Leonardo Clavijo	3
11	Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction. 2009 ·PubMed ·(unknown), (unknown), Ray Matthews, Leonardo Clavijo	0
12	Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents 2006 ·Circulation ·Pramod K. Kuchulakanti, William W. Chu, Rebecca Torguson, Patrick Ohlmann, Seung‐Woon Rha, Leonardo Clavijo, Sang‐Wook Kim, (unknown), Natalie Gevorkian, Zhenyi Xue, Kimberly A. Smith, J. Fournadjieva, William O. Suddath, Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent, Ron Waksman	480
13	Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus 2006 ·The American Journal of Cardiology ·Pramod K. Kuchulakanti, William W. Chu, Rebecca Torguson, Leonardo Clavijo, Roswitha Wolfram, Sundeep Mishra, Zhenyi Xue, Natalie Gevorkian, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman	34
14	Impact of Three or More Versus a Single Sirolimus-Eluting Stent on Outcomes in Patients Who Undergo Percutaneous Coronary Intervention 2006 ·The American Journal of Cardiology ·William W. Chu, Pramod K. Kuchulakanti, Seung‐Woon Rha, (unknown), (unknown), Rebecca Torguson, Betty Wang, Zhenyi Xue, Leonardo Clavijo, William O. Suddath, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman	11
15	Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures 2006 ·Cardiovascular revascularization medicine ·Aamir Javaid, William W. Chu, Édouard Cheneau, Leonardo Clavijo, Lowell F. Satler, Kenneth M. Kent, Neil J. Weissman, Augusto D. Pichard, Ron Waksman	19
16	Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials 2006 ·American Journal of Physiology-Heart and Circulatory Physiology ·Stephan Zbinden, Leonardo Clavijo, Birgit Kantor, (unknown), (unknown), James A. Andrews, Gil Jin Jang, Mary Susan Burnett, Stephen E. Epstein	28
17	Impact of Chronic Renal Insufficiency on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Bare Metal Stents 2006 ·The American Journal of Cardiology ·Pramod K. Kuchulakanti, Rebecca Torguson, William W. Chu, Daniel Caños, Seung‐Woon Rha, Leonardo Clavijo, Regina Deible, Natalie Gevorkian, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman	46
18	The potential role of resistin in atherogenesis 2005 ·Atherosclerosis ·Mary Susan Burnett, Cheol W. Lee, Tim Kinnaird, Eugenio Stabile, Sarfraz Durrani, Mercedes Dullum, Joseph M. Devaney, (unknown), Sotiris C. Stamou, Daniel Caños, Stephan Zbinden, Leonardo Clavijo, Gil Jin Jang, James A. Andrews, Jianhui Zhu, Stephen E. Epstein	195
19	“Hybrid” approach for the treatment of a giant left main coronary artery aneurysm 2004 ·PubMed ·Leonardo Clavijo, Pramod K. Kuchulakanti, William W. Chu, (unknown), Augusto D. Pichard, Ron Waksman, Steven W. Boyce, Lowell F. Satler, Kenneth M. Kent	1
20	Platelet-Activating Factor and Bacteremia-Induced Pulmonary Hypertension 2000 ·Journal of Surgical Research ·Leonardo Clavijo, (unknown), Paul J. Matheson, (unknown), Mark A. Wilson, William B. Wead, R. Neal Garrison	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact